|
1
|
Guggenheim DE and Shah MA: Gastric cancer
epidemiology and risk factors. J Surg Oncol. 107:230–236. 2013.
View Article : Google Scholar
|
|
2
|
Yeoh KG: How do we improve outcomes for
gastric cancer? J Gastroenterol Hepatol. 22:970–972. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tan IB, Ng I, Tai WM and Tan P:
Understanding the genetic basis of gastric cancer: Recent advances.
Expert Rev Gastroenterol Hepatol. 6:335–341. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagini S: Carcinoma of the stomach: A
review of epidemiology, pathogenesis, molecular genetics and
chemoprevention. World J Gastrointest Oncol. 4:156–169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stambolic V, Suzuki A, de la Pompa JL,
Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM,
Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent
cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
She QB, Solit DB, Ye Q, O'Reilly KE, Lobo
J and Rosen N: The BAD protein integrates survival signaling by
EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor
cells. Cancer Cell. 8:287–297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang LL, Liu J, Lei S, Zhang J, Zhou W
and Yu HG: PTEN inhibits the invasion and metastasis of gastric
cancer via downregulation of FAK expression. Cell Signal.
26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Katoh M: WNT/PCP signaling pathway and
human cancer (review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI
|
|
9
|
Chen Z, Trotman LC, Shaffer D, Lin HK,
Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al:
Crucial role of p53-dependent cellular senescence in suppression of
Pten-deficient tumorigenesis. Nature. 436:725–730. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu WT, Yang Z and Lu NH: Roles of PTEN
(Phosphatase and Tensin Homolog) in gastric cancer development and
progression. Asian Pac J Cancer Prev. 15:17–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koike H, Nozawa M, De Velasco MA, Kura Y,
Ando N, Fukushima E, Yamamoto Y, Hatanaka Y, Yoshikawa K, Nishio K
and Uemura H: Conditional PTEN-deficient mice as a prostate cancer
chemoprevention model. Asian Pac J Cancer Prev. 16:1827–1831. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kechagioglou P, Papi RM, Provatopoulou X,
Kalogera E, Papadimitriou E, Grigoropoulos P, Nonni A, Zografos G,
Kyriakidis DA and Gounaris A: Tumor suppressor PTEN in breast
cancer: Heterozygosity, mutations and protein expression.
Anticancer Res. 34:1387–1400. 2014.PubMed/NCBI
|
|
13
|
Nakanishi A, Kitagishi Y, Ogura Y and
Matsuda S: The tumor suppressor PTEN interacts with p53 in
hereditary cancer (Review). Int J Oncol. 44:1813–1819. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim DK, Alvarado CS, Abramowsky CR, Gu L,
Zhou M, Soe MM, Sullivan K, George B, Schemankewitz E and Findley
HW: Expression of inhibitor-of-apoptosis protein (IAP) livin by
neuroblastoma cells: Correlation with prognostic factors and
outcome. Pediatr Dev Pathol. 8:621–629. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kleinberg L, Lie AK, Florenes VA, Nesland
JM and Davidson B: Expression of inhibitor-of-apoptosis protein
family members in malignant mesothelioma. Hum Pathol. 38:986–994.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li CJ, Cong Y, Liu XZ, Zhou X, Shi X, Wu
SJ, Zhou GX and Lu M: Research progress on the livin gene and
osteosarcomas. Asian Pac J Cancer Prev. 15:8577–8579. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ou JM, Ye B, Qiu MK, Dai YX, Dong Q, Shen
J, Dong P, Wang XF, Liu YB, Quan ZW and Fei ZW: Knockdown of Livin
inhibits growth and invasion of gastric cancer cells through
blokkade of the MAPK pathway in vitro and in vivo. Int J Oncol.
44:276–284. 2014. View Article : Google Scholar
|
|
18
|
Chung CY, Park YL, Kim N, Park HC, Park
HB, Myung DS, Kim JS, Cho SB, Lee WS and Joo YE: Expression and
prognostic significance of Livin in gastric cancer. Oncol Rep.
30:2520–2528. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crnković-Mertens I, Wagener N, Semzow J,
Gröne EF, Haferkamp A, Hohenfellner M, Butz K and Hoppe-Seyler F:
Targeted inhibition of Livin resensitizes renal cancer cells
towards apoptosis. Cell Mol Life Sci. 64:1137–1144. 2007.
View Article : Google Scholar
|
|
20
|
Zhao CL, Wang JX, Zhang XF, Zhao GQ and
Wang ZJ: Construction and identification of gene vector expressing
PTEN while simultaneously silencing Livin. Zhonghua Yi Xue Za Zhi.
90:2428–2432. 2010.In Chinese. PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Hwang TL, Changchien TT, Wang CC and Wu
CM: Claudin-4 expression in gastric cancer cells enhances the
invasion and is associated with the increased level of matrix
metalloproteinase-2 and -9 expression. Oncol Lett. 8:1367–1371.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krajewska M, Wang HG, Krajewski S, Zapata
JM, Shabaik A, Gascoyne R and Reed JC: Immunohistochemical analysis
of in vivo patterns of expression of CPP32 (Caspase-3), a cell
death protease. Cancer Res. 57:1605–1613. 1997.PubMed/NCBI
|
|
24
|
Schwartzbauer G and Robbins J: The tumor
suppressor gene PTEN can regulate cardiac hypertrophy and survival.
J Biol Chem. 276:35786–35793. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun CH, Chang YH and Pan CC: Activation of
the PI3K/Akt/mTOR pathway correlates with tumour progression and
reduced survival in patients with urothelial carcinoma of the
urinary bladder. Histopathology. 58:1054–1063. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kasof GM and Gomes BC: Livin, a novel
inhibitor of apoptosis protein family member. J Biol Chem.
276:3238–3246. 2001. View Article : Google Scholar
|
|
27
|
Hinds MG, Norton RS, Vaux DL and Day CL:
Solution structure of a baculoviral inhibitor of apoptosis (IAP)
repeat. Nat Struct Biol. 6:648–651. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chu ZL, McKinsey TA, Liu L, Gentry JJ,
Malim MH and Ballard DW: Suppression of tumor necrosis
factor-induced cell death by inhibitor of apoptosis c-IAP2 is under
NF-kappaB control. Proc Natl Acad Sci USA. 94:10057–10062. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang H and Schimmer AD: Livin/melanoma
inhibitor of apoptosis protein as a potential therapeutic target
for the treatment of malignancy. Mol Cancer Ther. 6:24–30. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma L, Huang Y, Song Z, Feng S, Tian X, Du
W, Qiu X, Heese K and Wu M: Livin promotes Smac/DIABLO degradation
by ubiquitin-proteasome pathway. Cell Death Differ. 13:2079–2088.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hwang PH, Yi HK, Kim DS, Nam SY, Kim JS
and Lee DY: Suppression of tumorigenicity and metastasis in B16F10
cells by PTEN/MMAC1/TEP1 gene. Cancer Lett. 172:83–91. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leslie NR: PTEN: An intercellular
peacekeeper? Sci Signal. 5:pe502012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maehama T, Taylor GS and Dixon JE: PTEN
and myotubularin: novel phosphoinositide phosphatases. Annu Rev
Biochem. 70:247–279. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen F, Yang D, Che X, Wang J, Li X, Zhang
Z, Chen X and Song X: Livin mediates tumor cell invasion in the
DU-145 cell line via NF-κB. Oncol Rep. 27:2010–2016.
2012.PubMed/NCBI
|
|
35
|
Chen F, Yang D, Wang S, Che X, Wang J, Li
X, Zhang Z, Chen X and Song X: Livin regulates prostate cancer cell
invasion by impacting the NF-κB signaling pathway and the
expression of FN and CXCR4. IUBMB Life. 64:274–283. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoon TM, Kim SA, Lee DH, Lee JK, Park YL,
Lee KH, Chung IJ, Joo YE and Lim SC: Expression of Livin and the
inhibition of tumor progression by Livin silencing in
laryngohypopharyngeal cancer. In Vivo. 28:751–759. 2014.PubMed/NCBI
|
